FORM D
Notice of Exempt Offering of Securities

UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.

OMB APPROVAL
OMB Number: 3235-0076
Expires: August 31, 2015
Estimated Average burden hours per response: 4.0
1. Issuer's Identity
CIK (Filer ID Number)Previous Name(s)NoneEntity Type
0001549084
PN Med Group Inc.
PN Med Group Inc
Corporation
Limited Partnership
 Limited Liability Company
 General Partnership
 Business Trust
Other 
Name of Issuer
 EKSO BIONICS HOLDINGS, INC.
Jurisdiction of Incorporation/Organization
NEVADA 
Year of Incorporation/Organization
Over Five Years Ago
Within Last Five Years (Specify Year)
2012
Yet to Be Formed
 
  
  
 
2. Principal Place of Business and Contact Information
Name of Issuer
 EKSO BIONICS HOLDINGS, INC.
Street Address 1Street Address 2
 1414 HARBOUR WAY SOUTH
 SUITE 1201
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 RICHMOND
 CALIFORNIA
 
 94804
 (203) 723-3576 



3. Related Persons

Last NameFirst NameMiddle Name
Harding
Nathan
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)
Chief Executive Officer


Last NameFirst NameMiddle Name
Scheder-Bieschin
Max
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)
Chief Financial Officer, Treasurer and Secretary


Last NameFirst NameMiddle Name
Looby
Thomas
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)
President and Chief Commercial Officer


Last NameFirst NameMiddle Name
Angold
Russ
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)
Chief Technology Officer


Last NameFirst NameMiddle Name
Boren
Daniel
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)


Last NameFirst NameMiddle Name
Hamilton
Marilyn
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)


Last NameFirst NameMiddle Name
Sherman
Steven
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)


Last NameFirst NameMiddle Name
Peurach
Jack
Street Address 1Street Address 2
 Ekso Bionics Holdings, Inc. 
 1414 Harbour Way South, Suite 1201
CityState/Province/CountryZIP/Postal Code
 Richmond
 CALIFORNIA
 94804
 
Relationship:Executive OfficerDirectorPromoter
Clarification of Response (if Necessary)




4. Industry Group
 Agriculture
Banking & Financial Services
  Commercial Banking
  Insurance
 Investing
  Investment Banking
  Pooled Investment Fund

 Other Banking & Financial Services
 Business Services
Energy
  Coal Mining
  Electric Utilities
  Energy Conservation
  Environmental Services
  Oil & Gas
  Other Energy
Health Care
  Biotechnology
  Health Insurance
  Hospitals & Physicians
  Pharmaceuticals
  Other Health Care
   
   
   
  
 Manufacturing
Real Estate
 Commercial
 Construction
 REITS & Finance
 Residential
Other Real Estate
 Retailing
Restaurants
Technology
 Computers
 Telecommunications
 Other Technology
Travel
 Airlines & Airports
 Lodging & Conventions
 Tourism & Travel Services
 Other Travel
Other

  
   
5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
 $1 - $1,000,000$1 - $5,000,000
 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
 Over $100,000,000 Over $100,000,000
 Decline to Disclose Decline to Disclose
 Not Applicable Not Applicable

 
6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
Rule 504(b)(1) (not (i), (ii)
or (iii))		Rule 505      
Rule 504 (b)(1)(i) Rule 506(b)
Rule 504 (b)(1)(ii) Rule 506(c)
Rule 504 (b)(1)(iii)Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
 
 

7. Type of Filing
 New Notice Date of First Sale 
2014-11-20
 First Sale Yet to Occur
 Amendment


 
 
8. Duration of Offering
Does the Issuer intend this offering to last more than one year?  Yes  No
 
 
9. Type(s) of Securities Offered (select all that apply)
Pooled Investment Fund InterestsEquity
Tenant-in-Common Securities Debt
Mineral Property SecuritiesOption, Warrant or Other Right to Acquire Another Security
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire SecurityOther (describe)
 
 
 
10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?  Yes  No
Clarification of Response (if Necessary)
 
 
 
11. Minimum Investment
Minimum investment accepted from any outside investor$
 0
USD

12. Sales Compensation
Recipient Recipient CRD NumberNone
 Katalyst Securities LLC
 112494
(Associated) Broker or DealerNone(Associated) Broker or Dealer CRD Number None
 EDI Financial, Inc.
 15699
Street Address 1      Street Address 2
15 MAIDEN LANE, SUITE 601
 
City State/Province/CountryZIP/Postal Code
 NEW YORK
 NEW YORK
 10038
State(s) of SolicitationAll StatesForeign/Non-US
 
ARIZONA
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
FLORIDA
GEORGIA
HAWAII
ILLINOIS
INDIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
NEW HAMPSHIRE
NEW JERSEY
NEW YORK
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
SOUTH DAKOTA
TEXAS
VIRGINIA
WASHINGTON
WISCONSIN
Recipient Recipient CRD NumberNone
 Katalyst Securities LLC
 112494
(Associated) Broker or DealerNone(Associated) Broker or Dealer CRD Number None
 Dinosaur Securities L.L.C.
 104446
Street Address 1      Street Address 2
15 MAIDEN LANE, SUITE 601
 
City State/Province/CountryZIP/Postal Code
 NEW YORK
 NEW YORK
 10038
State(s) of SolicitationAll StatesForeign/Non-US
 
ARIZONA
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
FLORIDA
GEORGIA
HAWAII
ILLINOIS
INDIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
NEW HAMPSHIRE
NEW JERSEY
NEW YORK
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
SOUTH DAKOTA
TEXAS
VIRGINIA
WASHINGTON
WISCONSIN



13. Offering and Sales Amounts
 
Total Offering Amount $
30300000
USDIndefinite
Total Amount Sold $
22755500
USD
Total Remaining to be Sold $
7544500
USDIndefinite
Clarification of Response (if Necessary)
  
 
14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
   
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
157
 
15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$
1137775
USDEstimate
Finders' Fees$
0
USDEstimate
Clarification of Response (if Necessary)
 
 

16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 
2400000
USDEstimate
Clarification of Response (if Necessary)
Certain proceeds will be used by the Company for general working capital, including compensation expected to be paid to certain executive officers and/or directors who are listed as Related Persons herein over a 24 month period.

Signature and Submission
 
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission 
 In submitting this notice, each Issuer named above is: 
 
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, the information furnished to offerees.
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the Issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against it in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Regulation D for one of the reasons stated in Rule 505(b)(2)(iii) or Rule 506(d).
 
Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.
 
IssuerSignatureName of SignerTitleDate
EKSO BIONICS HOLDINGS, INC./s/ Max Scheder-BieschinMax Scheder-BieschinChief Financial Officer2014-12-04